Proffered paper session 1


Room: Hall 1C

Breast symptoms and the risk of subsequent interval cancers and lethal breast cancers
New genetic testing delivery model for breast cancer patients
A murine model displaying human BRCAness characteristics based on molecular and tumour infiltrating lymphocyte patterns
Pan-cancer estimation of tumour purity and stromal composition reveals genomic drivers of immune evasion
A microenvironment secretome screen reveals FGF2-mediated resistance to anti-estrogens and PI3K/mTOR inhibitors in ER+ breast cancer